PARP1 and cancer: Therefore, the cell-protective role of PARP-1 (against mild oxidative stress, as evident from this study) could have been implicated in those therapy-resistant cancer cells where cells survive in a dormancy stage (although they are metabolically active) but grow back with tumorigenic potential [66].